On January 3, 2013 the Rafarma Pharmaceuticals, Inc. trading symbol was changed to “RAFA”. With the culmination of the Russian Holidays on January 14 (old New Year), the manufacturing facility located in Lipetsk, Russia will resume production with a goal of full production in the second quarter.
In preparation for the upcoming public awareness campaign the Company has set up a Twitter account, a Facebook account and a Text Communication Account.
Please visit http://twitter.com/rafarmainfo to access Twitter.
Visit http://facebook.com/rafarmainfo to access Facebook.
To receive daily updates on the company via text message text the word RAFA to the number 74499 (U.S. only).
These sites will be used for investor awareness and all information derived from our friends will be kept strictly confidential.
Safe Harbor Statement
Matters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words "anticipate," "believe," "estimate,", "may," "intend," "expect" and similar expressions identify such forward-looking statements. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include but are not limited to: the impact of economic, competitive and other factors affecting the Company and its operations, markets, product, and distributor performance.
SOURCE: Rafarma Pharmaceuticals, Inc.